In the April issue of PME there’s an extended look at real world data and the rise of the observational data in healthcare, though we find there’s still a way to go before its promise is fully seen.
We talk to Sanofi’s executive vice president, global divisions and strategic development Pascale Witz about her career and driving change at the French pharma company.
There’s a look too at the issue of drug pricing – something of a lightening rod for pharma at the moment – and we hear from industry and politicians on how pricing and access could be addressed.
This issue also has an interview with AstraZeneca’s director of marketing Chris Boulton about his firm’s efforts in diabetes, innovations in the area and why we still need more, and better, diabetes medicines in the future.
And finally, don’t forget to look out for our Digital Doctors supplement in the May issue of PME.
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
PME is also available to download as an app for iPhone and iPad
